1. Reanalysis of the Rituximab in ANCA-Associated Vasculitis trial identifies granulocyte subsets as a novel early marker of successful treatment. Issue 1 (December 2015) Authors: Nasrallah, Mazen; Pouliot, Yannick; Hartmann, Bjoern; Dunn, Patrick; Thomson, Elizabeth; Wiser, Jeffrey; Butte, Atul Journal: Arthritis research & therapy Issue: Volume 17:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗